BRANMOOR
TUESDAY ยท 12 MAY 2026

Isoleucine, Leucine, Lysine Acetate, Methionine, Phenylalanine, Threonine, Tryptophan, Valine, Alanine, Arginine, Aspartic Acid, Glutamic Acid, Glycine, Histidine, Proline, Serine, Taurine, And Tyrosine

Injection · trading as Aminosyn-Pf

Current FDA record updated

FDA shortage record

Substance
Isoleucine, Leucine, Lysine Acetate, Methionine, Phenylalanine, Threonine, Tryptophan, Valine, Alanine, Arginine, Aspartic Acid, Glutamic Acid, Glycine, Histidine, Proline, Serine, Taurine, And Tyrosine
Brand name
Aminosyn-Pf
Manufacturer
ICU Medical Inc.
Dosage form
Injection
Presentation
Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03)
Route(s)
INTRAVENOUS
Therapeutic category
Gastroenterology
Package NDC
0990-4178-03
Initially posted
12/08/2020
Current FDA status
Current

Reason and context

Reason reported: Shortage of an active ingredient

ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-4178-03

Manufacturer contact

Per the FDA record, the manufacturer's contact for supply inquiries is 1-866-829-9025 or [email protected].

If you're affected by this shortage

  • Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
  • Ask your pharmacy to check supply across multiple wholesalers and other branches.
  • Check current pharmacy pricing and availability via GoodRx (affiliate link).
  • Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.

Sources

Important

This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.